Insider Transactions Reported by 20 Insiders of MANNKIND CORP

Symbol
MNKD on Nasdaq
Location
Danbury, CT

Insiders trading volume in the past year

MANNKIND CORP executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael Castagna Chief Executive Officer, Director $15.1M -$1.25M -7.66% 17 Dec 2025
Stuart A. Tross Chief People & Workpl Officer $5.51M -$251K -4.36% 16 Sep 2025
David Thomson EVP Genl Counsel & Secretary $4.69M -$1.01M -17.8% 02 Dec 2025
Steven B. Binder Director $3.27M -$982K -23.1% 15 Jul 2025
Alejandro Galindo EVP Endocrine Business Unit $3.11M 22 Aug 2022
Joseph Kocinsky Chief Technology Officer $2.98M 27 Aug 2022
Sanjay R. Singh EVP Technical Operations $2.29M -$94.4K -3.96% 14 Nov 2025
BURKHARD BLANK EVP Chief Medical Officer $1.77M 15 Jul 2025
Ajay Ahuja Chief Medical Officer $1.71M 11 Nov 2025
Dominic Marasco Pres, Endocrine Business Unit $1.52M 23 Jun 2025
Lauren Sabella EVP Operations $1.35M 15 Jul 2025
Christopher Prentiss Chief Financial Officer $1.32M 15 Jul 2025
ANTHONY C. HOOPER Director $917K 14 May 2025
James Samuel Shannon Director 14 May 2025
Michael A. Friedman Director 14 May 2025
Sabrina Kay Director 14 May 2025
KENT KRESA Director 15 May 2024
CHRISTINE MUNDKUR Director 14 May 2025
Jennifer Grancio Director 14 May 2025
RONALD J. CONSIGLIO Director 14 May 2025

Recent Insider Transactions by Companies or Individuals for MANNKIND CORP

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.